BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27810399)

  • 1. Associations between hemoglobin concentrations and the development of incidental metabolic syndrome or nonalcoholic fatty liver disease.
    Chung GE; Yim JY; Kim D; Kwak MS; Yang JI; Chung SJ; Yang SY; Kim JS
    Dig Liver Dis; 2017 Jan; 49(1):57-62. PubMed ID: 27810399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents.
    Pacifico L; Bonci E; Andreoli G; Romaggioli S; Di Miscio R; Lombardo CV; Chiesa C
    Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):737-43. PubMed ID: 24656140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemoglobin combined with triglyceride and ferritin in predicting non-alcoholic fatty liver.
    Jiang Y; Zeng J; Chen B
    J Gastroenterol Hepatol; 2014; 29(7):1508-14. PubMed ID: 24628002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The associations between apolipoprotein B, A1, and the B/A1 ratio and nonalcoholic fatty liver disease in both normal-weight and overweight Korean population.
    Yang MH; Sung J; Gwak GY
    J Clin Lipidol; 2016; 10(2):289-98. PubMed ID: 27055959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A vegetarian diet does not protect against nonalcoholic fatty liver disease (NAFLD): A cross-sectional study between Buddhist priests and the general population.
    Choi SH; Oh DJ; Kwon KH; Lee JK; Koh MS; Lee JH; Kang HW
    Turk J Gastroenterol; 2015 Jul; 26(4):336-43. PubMed ID: 26039004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk.
    Du T; Yu X; Yuan G; Zhang J; Sun X
    Cardiovasc Diabetol; 2015 Oct; 14():144. PubMed ID: 26511621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity.
    Zhu WH; Fang LZ; Lu CR; Dai HL; Chen JH; Qiao QH; Chen LY
    World J Gastroenterol; 2015 Sep; 21(35):10192-9. PubMed ID: 26401084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM; Farghaly AG; El-Ghitany EM
    Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The visceral adiposity index is a predictor of incident nonalcoholic fatty liver disease: A population-based longitudinal study.
    Okamura T; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
    Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):375-383. PubMed ID: 32434704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease.
    Zelber-Sagi S; Salomone F; Yeshua H; Lotan R; Webb M; Halpern Z; Santo E; Oren R; Shibolet O
    Liver Int; 2014 Jul; 34(6):e128-35. PubMed ID: 24118857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women.
    Liu PJ; Ma F; Lou HP; Zhu YN; Chen Y
    Climacteric; 2014 Dec; 17(6):692-9. PubMed ID: 24884478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High red blood cell distribution width is closely associated with nonalcoholic fatty liver disease.
    Yang W; Huang H; Wang Y; Yu X; Yang Z
    Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):174-8. PubMed ID: 24025980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease.
    Zhang S; Du T; Zhang J; Lu H; Lin X; Xie J; Yang Y; Yu X
    Lipids Health Dis; 2017 Jan; 16(1):15. PubMed ID: 28103934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in the impact of nonalcoholic fatty liver disease on cardiovascular risk factors.
    Du T; Sun X; Yuan G; Zhou X; Lu H; Lin X; Yu X
    Nutr Metab Cardiovasc Dis; 2017 Jan; 27(1):63-69. PubMed ID: 27956025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol.
    Wu KT; Kuo PL; Su SB; Chen YY; Yeh ML; Huang CI; Yang JF; Lin CI; Hsieh MH; Hsieh MY; Huang CF; Lin WY; Yu ML; Dai CY; Wang HY
    J Clin Lipidol; 2016; 10(2):420-5.e1. PubMed ID: 27055973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease.
    Suh JB; Kim SM; Cho GJ; Choi KM
    Scand J Gastroenterol; 2014 Aug; 49(8):979-85. PubMed ID: 24957697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triglycerides to high-density lipoprotein cholesterol ratio as a surrogate for nonalcoholic fatty liver disease: a cross-sectional study.
    Fan N; Peng L; Xia Z; Zhang L; Song Z; Wang Y; Peng Y
    Lipids Health Dis; 2019 Feb; 18(1):39. PubMed ID: 30711017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Serum Sialic Acid Levels and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study.
    He J; Mao W; Zhang J; Jin X
    Ann Nutr Metab; 2015; 67(2):69-75. PubMed ID: 26315777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of metabolic factors for nonalcoholic Fatty liver disease in women.
    Chung GE; Yim JY; Kim D; Lim SH; Yang JI; Kim YS; Yang SY; Kwak MS; Kim JS; Cho SH
    Biomed Res Int; 2015; 2015():131528. PubMed ID: 25973422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults.
    Lee YJ; Lee HR; Lee JH; Shin YH; Shim JY
    Clin Chem Lab Med; 2010 Feb; 48(2):175-80. PubMed ID: 19961393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.